子宫内膜异位症腹腔镜术后复发的相关因素分析

目的：探讨子宫内膜异位症患者腹腔镜手术后复发的危险因素，为临床治疗提供依据。方法：回顾分析2009年5月至2011年5月134例子宫内膜异位症患者（Ⅰ、Ⅱ期62例，Ⅲ期49例，Ⅳ期23例）腹腔镜术后复发情况，并对相关影响因素进行logistic回归风险分析，筛查复发的相关因素。结果：经logistic回归分析显示，纳入分析的患者复发率为16．4％（22／134），与内异症患者术后复发率相关的因素有r-AFS分期（OR=5．785，CI=1．939—17．261，P=0．002）、手术方式（OR=0．301．CI=0．109-0．830，P=0．020）、术后联合用药（OR=0．062，CI=0．016—0．234，P=0．000）。结论：r—AFS分期、手术方式及术后联合用药是影响子宫内膜异位症患者腹腔镜手术后复发率的相关因素，临床应加强干预，以降低术后复发率。

Correlation factors analysis of endometriosis recurrence after laparoscopic surgery

Objective ： To investigate the factors correlated to the endometriosis recurrence after treatment with laparoscopic sur- gery and provide basis for clinical treatment. Methods：The recurrence situation of 134 patients with endometriosis undergoing laparo- scopic surgery during May 2009 and May 2011 were analyzed retrospectively. There were 62 cases of r-AFS stage Ⅰ and Ⅱ ,49 cases of stage Ⅲ and 23 cases of stage Ⅳ. Related factors were analyzed with logistic regression to screen relative factors of recurrence. Results： Logistic regression analysis revealed that a total of 22 （ 16.4% ） in 134 patients investigated suffered from recurrence. Factors that might significantly （P〈0. 05） correlate with recurrence of endometriosis included r-AFS scores （ OR = 5. 785, CI = 1. 939-17. 261, P = 0.002）, surgical procedures （ OR = 0.301, CI = 0. 109-0. 830, P = 0. 020） and postoperative medication （ OR = 0. 062, CI = 0. 016- 0. 234, P = 0. 000）. Conclusions： R-AFS scores, surgical procedures and postoperative medication are key factors of endometriosis re- currence after laparoscopic surgery. Clinical interventions should be strengthened to reduce the recurrence rate.